Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis

• Main Authors: Zhang N (Author), Zhang C (Author), Zeng Z (Author), Zhang J (Author), Du S (Author), Bao C (Author), Wang Z (Author)
• Format: Book
• Published: Dove Medical Press, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ning Zhang,1 Changqing Zhang,2 Zhihong Zeng,1 Jiyong Zhang,1 Shengnan Du,1 Chunde Bao,3 Zhe Wang1 1Longwood Biopharmaceuticals, Shanghai, People’s Republic of China; 2Department of Orthopaedics, Shanghai Sixth People’s Hospital, Shanghai, People’s Republic of China; 3De...